glp-1 analogs Classification of currently available glucagon-like peptide-1 receptor GLP-1 Receptor Agonists – Peripheral

However, in people with Crohn's disease, distinguishing between medication side effects and disease flares can be challenging

Allen PJ et al

Andrologia 51:e13267

Never apply concentrations above 1% daily without breaks

Patients who develop sustainable eating habits and consistent exercise routines while on medication sometimes maintain weight loss for longer intervals if they eventually reduce doses, though complete cessation still typically results in rebound weight gain

Because Swaney was identified as a participant with pre-diabetes, she was asked to continue with the study for 190 weeks to determine whether the medication had any impact on the development of diabetes